OTC Pharmaceuticals - Uruguay

Uruguay

Revenue in the OTC Pharmaceuticals market amounts to €261.50 in 2024. The market is expected to grow annually by 6.27% (CAGR 2024-2029).
The market's largest segment is the segment Analgesics with a market volume of €69.21 in 2024.
In global comparison, most revenue is generated in the United States (€38,250 in 2024).
In relation to total population figures, per person revenues of €76.39 are generated in 2024.
In the OTC Pharmaceuticals market, 1.2% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The OTC Pharmaceuticals market in Uruguay has been experiencing steady growth over the past few years.

Customer preferences: Customers in Uruguay have shown a growing preference for over-the-counter (OTC) medications due to their convenience and accessibility. OTC medications do not require a prescription, allowing customers to easily purchase them from pharmacies or supermarkets. This convenience is particularly appealing to busy individuals who may not have the time to visit a doctor for minor ailments. Moreover, OTC medications often offer a more affordable option compared to prescription drugs, making them a popular choice among price-conscious consumers.

Trends in the market: One key trend in the OTC Pharmaceuticals market in Uruguay is the increasing demand for self-care and preventive healthcare. As people become more health-conscious, they are actively seeking ways to maintain their well-being and prevent illnesses. This has led to a rise in the consumption of OTC medications, such as vitamins, supplements, and preventive treatments. Additionally, the aging population in Uruguay has contributed to the growth of the OTC Pharmaceuticals market, as older individuals often require medications for chronic conditions that can be managed with OTC products.

Local special circumstances: Uruguay has a well-developed healthcare system that provides universal coverage to its citizens. However, due to the limited resources and budget constraints, the government has been encouraging self-care and the use of OTC medications for minor ailments. This has created a favorable environment for the OTC Pharmaceuticals market to thrive. Additionally, the high literacy rate in Uruguay has played a role in the growth of the market, as consumers are more informed and empowered to make their own healthcare decisions.

Underlying macroeconomic factors: Uruguay has experienced stable economic growth in recent years, which has positively impacted the OTC Pharmaceuticals market. As the economy improves, consumers have more disposable income to spend on healthcare products, including OTC medications. Furthermore, the increasing urbanization and changing lifestyle patterns in Uruguay have contributed to the growth of the market. Urban dwellers often have access to a wider range of OTC medications and are more likely to prioritize their health and well-being. In conclusion, the OTC Pharmaceuticals market in Uruguay is witnessing steady growth due to customer preferences for convenience and affordability, as well as the increasing demand for self-care and preventive healthcare. The local special circumstances, such as the government's encouragement of self-care and the high literacy rate, have created a favorable environment for the market. The underlying macroeconomic factors, including stable economic growth and changing lifestyle patterns, have also contributed to the market's development.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.